KOSDAQ · Healthcare · ₩90B
₩600-0.83%
What's this stock's score right now?
See its score for free — revenue and money flow, graded on one standard.
Quarterly Financials
6/'26
3/'26 vs prev quarter
Short Volume 7.9% · as of 26.09.11
Among 98 제약 peers
Quarterly Revenue Growth
“신약 성장 기반은 갖췄고 본업 수익성 회복을 봐야 해요.”
In the company's words · 2026 2분기 filing